Publication | Open Access

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs

Cancer ImmunosurveillanceMultivalent ScfvsImmunologyImmunoeditingPathologyTherapeutic VaccineThomsen-friedenreich DisaccharideTumor TargetingVivo TumorImmunotherapyMedicineCancer ResearchTumor MicroenvironmentTumor Biology